By Dean SealShares of Twist Bioscience rose after the company recorded a narrower loss and higher revenue than analysts had been expecting in its fiscal first quarter. The stock was up 8.7% at $36.14 in midday trading. Shares are 2.5% off from where they started the year.

Source: Wall Street Journal February 03, 2024 13:39 UTC